Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (1039)

« Back to Publications

Report of a one-day convening on regulatory science, practices, and innovative approaches to facilitate approval of novel combination vaccines.

Hausdorff WP. et al, (2026), Vaccine, 75

An Adenoviral Vectored Vaccine Protects Mice Against Aerosol Challenge with Yersinia pestis.

Dold C. et al, (2026), Mol Ther

Predicting Salmonella Typhi incidence using prevalence metrics from sentinel studies of community-onset bloodstream infections

Hagedoorn N. et al, (2026)

The effect of pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine on nasopharyngeal colonisation following human infection challenge with serotype 3 and serotype 6B (PREVENTING PNEUMO 2): a double-masked, randomised, controlled, phase 4 trial.

Liatsikos K. et al, (2026), Lancet Microbe

A risk to child health: confusion and concern over changes to US vaccine policy.

Pollard AJ. and Plotkin S., (2026), Lancet, 407, 553 - 556

Machine learning-driven identification of serotype-independent pneumococcal vaccine candidates using samples from human infection challenge studies.

Cheliotis KS. et al, (2026), Vaccine, 75

Causes of Fever in a Cohort of Nepali Children and the Potential Impact of Molecular Testing During a Dengue Fever Outbreak.

O'Reilly PJ. et al, (2026), Pediatr Infect Dis J

Phase II multicentre double-blind randomised controlled trial of a Bivalent VaccInation against Salmonella Typhi and Paratyphi A (BiVISTA) using a controlled human infection model of paratyphoid A infection: study protocol.

Paganotti Vicentine M. et al, (2026), BMJ Open, 16

P-1471. Impact of PCV10 Introduction on Nasopharyngeal Carriage of Streptococcus pneumoniae in Healthy Children in Rural and Urban Nepal

Gautam MC. et al, (2026), Open Forum Infectious Diseases, 13

Nasal Gene Expression in ART-Naive Adults with HIV and Pulmonary Tuberculosis in Uganda.

Khambati N. et al, (2026), medRxiv

Typhoid toxin of Salmonella Typhi elicits host antimicrobial response during acute typhoid fever.

Srour S. et al, (2026), EMBO Mol Med, 18, 187 - 216

Public attitudes towards intranasal and ultrasound mediated vaccine delivery: A cross-sectional study in the United Kingdom and United States.

Kantor J. et al, (2026), Vaccine, 69

Persistence of Immune Responses 5 Years After Vaccination With a Single Dose of Typhoid Conjugate Vaccine (TCV) in Nepalese Children

Pant D. et al, (2026)

Eight-Year Vaccine Protection Following a Single Dose of VI-Tetanus Toxoid Conjugate Vaccine in Nepali Children: Extended Follow-Up of the TyVAC Nepal Randomised Controlled Trial

Pant D. et al, (2026)

Impact of Dosing Interval on Immunogenicity Following a Heterologous Typhoid Conjugate Vaccine Booster in Nepalese Children: An Observational Study

Zhang Y. et al, (2026)

Load More

1
2
3
4
5
6
7
...
»